Ami, Japan

Tetsuo Sekiya


Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Amimachi, JP (1982)
  • Ibaraki, JP (1986)
  • Ami, JP (1980 - 1987)

Company Filing History:


Years Active: 1980-1987

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tetsuo Sekiya: Innovator in Pharmaceutical Chemistry

Introduction

Tetsuo Sekiya is a notable inventor based in Ami, Japan, recognized for his contributions to pharmaceutical chemistry. He holds a total of 4 patents, showcasing his innovative approach to drug development and chemical compounds.

Latest Patents

Among his latest patents is the invention of a 2-Phenylalkyl-3-aminoalkyl-4(3H)-quinazolinone compound. This compound is characterized by its diverse chemical structure, which includes various substituents that enhance its pharmacological properties. The invention highlights its calcium antagonistic, vasodilative, and antihypertensive activities, making it a significant advancement in the treatment of hypertension. Another notable patent involves novel quinazoline derivatives, which exhibit excellent antihypertensive activities, further emphasizing Sekiya's focus on developing effective pharmaceutical compositions.

Career Highlights

Throughout his career, Tetsuo Sekiya has worked with prominent companies such as Mitsubishi Yuka Pharmaceutical Co., Ltd. and Mitsubishi Chemical Industries Limited. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.

Collaborations

Sekiya has collaborated with esteemed colleagues, including Hidetoshi Hiranuma and Susumu Mizogami. These partnerships have likely fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Tetsuo Sekiya's work in pharmaceutical chemistry, particularly in the development of quinazoline derivatives and other compounds, underscores his significant impact on the field. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…